Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Synageva BioPharma Corp (GEVA)  
$0.00 0.00 (0.00%) as of 4:30 Fri 2/14


Download
   
Exchange: Nasdaq National Market
Security Type: Common
Shares Out: 34,000,000
Market Cap: N/A
Last Volume: 18,050 Avg Vol: 18,000
52 Week Range: $238.6 - $238.6
Level I Sector: Health Care
Level II Sector: Drugs
Level III Sector: Biotechnology

Member Indexes:
    NASDAQ BIOTECHNOLOGY     NASDAQ COMPOSITE
    NASDAQ NNM COMPOSITE

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

                 
 
Company Profile  


 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 0
Total Buy Value $0 $0 $0 $0
Total People Bought 0 0 0 0
Total Buy Transactions 0 0 0 0
Total Shares Sold 0 0 0 0
Total Sell Value $0 $0 $0 $0
Total People Sold 0 0 0 0
Total Sell Transactions 0 0 0 0
End Date 2024-01-28 2023-10-27 2023-04-28 2022-04-28

   
Records found: 372
  Page 7 of 15  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Patel Sanj K President & CEO   •       •      –    2013-02-21 4 OE $0.95 $43,122 D/D 45,392 46,423     -
   Patel Sanj K President & CEO   •       •      –    2013-02-20 4 AS $49.49 $1,218,505 D/D (24,608) 1,031     -
   Patel Sanj K President & CEO   •       •      –    2013-02-20 4 OE $0.95 $23,378 D/D 24,608 25,639     -
   Goldberg Mark Alan SVP, Product Development   •       –      –    2013-02-01 4 AS $47.33 $210,892 D/D (4,417) 0     -
   Goldberg Mark Alan SVP, Product Development   •       –      –    2013-02-01 4 OE $0.95 $4,196 D/D 4,417 4,417     -
   Quinn Anthony SVP, Chief Medical Officer   •       –      –    2013-01-18 4 AS $50.08 $473,106 D/D (9,447) 15,035     -
   Quinn Anthony SVP, Chief Medical Officer   •       –      –    2013-01-18 4 OE $0.95 $8,975 D/D 9,447 24,482     -
   Quinn Anthony SVP, Chief Medical Officer   •       –      –    2013-01-17 4 AS $50.00 $10,000 D/D (200) 15,035     -
   Quinn Anthony SVP, Chief Medical Officer   •       –      –    2013-01-17 4 OE $0.95 $190 D/D 200 15,235     -
   Quinn Anthony SVP, Chief Medical Officer   •       –      –    2013-01-16 4 AS $50.07 $268,025 D/D (5,353) 15,035     -
   Quinn Anthony SVP, Chief Medical Officer   •       –      –    2013-01-16 4 OE $0.95 $335 D/D 353 20,388     -
   Boess Carsten SVP, Chief Financial Officer   •       –      –    2013-01-16 4 AS $49.12 $487,614 D/D (9,927) 0     -
   Boess Carsten SVP, Chief Financial Officer   •       –      –    2013-01-16 4 OE $1.70 $16,876 D/D 9,927 9,927     -
   Tisch Thomas J Director   –       •      –    2013-01-09 4 B $47.53 $999,984 I/I 21,039 373,560 2.1     -
   Baker Felix Director   –       •       •   2013-01-04 4 B $47.53 $40,862,492 I/I 859,720 176,920 2.25     -
   14159, L.p. Director   –       •       •   2013-01-04 4 B $47.53 $40,862,492 I/I 859,720 176,920 2.25     -
   Goldberg Mark Alan SVP, Product Development   •       –      –    2013-01-02 4 AS $47.52 $209,896 D/D (4,417) 0     -
   Goldberg Mark Alan SVP, Product Development   •       –      –    2013-01-02 4 OE $0.95 $4,196 D/D 4,417 4,417     -
   Heberlig Chris Vice President, Finance   •       –      –    2012-12-19 4 AS $45.83 $183,705 D/D (4,000) 0     -
   Heberlig Chris Vice President, Finance   •       –      –    2012-12-19 4 OE $0.95 $3,800 D/D 4,000 4,000     -
   Patel Sanj K President & CEO   •       •      –    2012-12-17 4 AS $45.97 $1,513,338 D/D (32,319) 1,031     -
   Patel Sanj K President & CEO   •       •      –    2012-12-17 4 OE $0.95 $30,703 D/D 32,319 33,350     -
   Patel Sanj K President & CEO   •       •      –    2012-12-14 4 AS $45.30 $601,629 D/D (13,281) 1,031     -
   Patel Sanj K President & CEO   •       •      –    2012-12-14 4 OE $0.95 $12,617 D/D 13,281 14,312     -
   Patel Sanj K President & CEO   •       •      –    2012-12-13 4 AS $45.12 $657,470 D/D (14,400) 1,031     -
  372 Records found
  1  2  3  4  5  6  7  8  9  Next   
  Page 7 of 15
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us